Microsoft word - aerotet forte.doc

SAFETY DATA SHEET
Virbac New Zealand Limited
Aerotet Forte
Section 1: Identification of the Substance and Supplier

Product name:
Aerotet Forte
Recommended use:
For the treatment of topical superficial infections of the skin and open wounds due to tetracycline sensitive organisms. Company details:
Address:
30 – 32 Stonedon Drive, East Tamaki Auckland Telephone number:
Customer service toll free number:
0800 VIRBAC (0800 847 222) (Mon – Fri, 8.30 am – 4.30 pm) www.virbac.co.nz Emergency telephone number:
National Poison Center: 0800 POISON (0800 764 766) New Zealand Emergency Service 111 Date of preparation:
Section 2: Hazards Identification

Hazard classifications:
6.3B, 6.4A, 9.1B
Priority identifier:
WARNING
KEEP OUT OF REACH OF CHILDREN
ECOTOXIC

Secondary identifiers:
6.3B = Causes mild skin irritation 6.4A = Causes serious eye irritation 9.1B = Toxic to aquatic life with long lasting effects Precautionary information:
Read label before use Wash thoroughly after handling Wear eye and face protection Avoid release to the environment Collect spillage Section 3: Composition / Information on Ingredients

Product components:
Ingredients
CAS Number
Proportion
Section 4: First Aid Measures
If in eyes rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. If eye irritation persists get medical advice/attention. If skin irritation occurs, remove clothing and flush affected area with water. Seek medical advice if irritation persists. Ingestion:
Rinse mouth and drink a glass of water. Do not induce vomiting. If symptoms persist, consult a doctor. Inhaled:
Remove the person from affected area to fresh air area. If any trouble breathing, get immediate medical attention. If irritation or symptoms persist, consult a doctor. Workplace facilities:
No specific workplace facilities required. Required instructions:
Hygiene practices:
Notes for medical personnel:
Section 5: Firefighting Measures
Type of hazard:
Fire hazard properties:
Regulatory requirements:
Extinguishing media and methods:
Carbon dioxide (CO2), extinguishing powder Hazchem code:
Recommended protective clothing:
Wear sufficient respiratory protection where necessary and protective clothing to minimize skin exposure. Section 6: Accidental Release Measures

Emergency procedures:
Wear sufficient respiratory protection where necessary and protective clothing to minimize skin exposure. If possible contain the spill. Place inert absorbent such as vermiculite, sand or dirt onto material. Use clean, non-sparking tools to collect the material and place into a suitable labeled container. Section 7: Handling and Storage

Precautions for safe handling:
Keep out of reach of children. Use face and eye protection when handling. Avoid release to the environment. Wash hands thoroughly after handling. Approved handlers:
Recommended Storage Conditions:
Store in original container in a cool, dry, ventilated place away from direct heat or sunlight. Keep container sealed when not in use. Store site requirements
Store protected from light at room temperature below 30°C. Section 8: Exposure Controls / Personal Protection
Workplace Exposure Standards:
No working exposure standards have been established. Application in the workplace:
Ensure adequate ventilation. Keep container sealed when not in use. Exposure standards outside the workplace: No tolerable exposure limit (TEL) or
environmental exposure limit (EEL) are set for this substance at this time. Personal protective Equipment (PPE):
Use face and eye protection when handling. Section 9: Physical and Chemical Properties

Description of product:
Specific gravity @ 25°C
Further specifications
Specific advice:
Section 10: Stability and Reactivity

Stability of the substance:
Conditions to avoid
Avoid high temperature and keep away from naked flames. Material to avoid:
Hazardous decomposition products:
Hazardous polymerization:
Specific Data
Section 11: Toxicological Information
Acute effects for individual ingredients only Oxytetracycline hydrochloride LD50: 6696 mg/Kg (mouse) Gentian violet LD50: 9600 mg/Kg (mouse) Eye Contact
Skin Contact
Inhalation
Inhalation of spray mist may cause irritation to the respiratory tract. Symptoms can include headaches, nausea and breathing difficulties. Section 12: Ecological Information
Oxytetracycline hydrochloride: 0.207mg/L EC50 No EEL is set for this substance at this time. Environmental risk and safety phrases:
Section13: Disposal Considerations

Disposal information:
Dispose of this product only by using according to the label, or at an approved landfill, or other approved facility. Dispose of empty container by wrapping with paper and placing in the garbage, in accordance with the Territorial Local Authority. Section14: Transport Information

Transport information:
Dangerous Goods Classification
UN No
:1950
Class: 2.1
Packing Group: None
Shipping Name: Aerosol
Section15: Regulatory Information

Registration number:
For conditions of registration see http://www.nzfsa.govt.nz/acvm/
HSNO Classification Title:
HSNO Approval Number:
HSR002149

For a full listing of controls see http://www.ermanz.govt.nz Section 16: Other Information

Date of Revision
For product information visit the Virbac website www.virbac.co.nz While the information set forth is believed to be accurate as of the date hereof, Virbac New Zealand Limited makes no warranty with respect hereto and disclaims all liability from reliance thereon.

Source: http://www.virbac.co.nz/p-virbacnzpuben/pdf/SDS/Aerotet_Forte.pdf

conceptpaints.com.au

SAFETY DATA SHEET 1. IDENTIFICATION PRODUCT(S): BENZOYL PEROXIDE HARDENER (50% w/w) Supplier In Australia: Address: 26 - 30 Charles Street, St Marys, Australia. 2760 Telephone Number: Emergency Telephone: +61 2 96732555 (Monday to Friday 8am to 5pm) Supplier In NZ: Address: 39 Burrows Street, Tauranga, New Zealand Telephone Number: Emergency Teleph

Anthra

War Profiteering Anthrax, Drug Transnationals and TRIPs Kavaljit Singh Against the backdrop of September 11th terrorist attacks in the US, the current anthrax crisishas, once again, raised highly controversial issues related to intellectual property rights. Just afew months back, the world witnessed heated debate on the patent controversy when the Phar-maceutical Manufacturers’ Assoc

Copyright © 2013-2018 Pharmacy Abstracts